United States · FDA National Drug Code directory
CHLORZOXAZONE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 16571-727_b4a7f61d-613e-4d8f-a3fc-37143c6e19c3
- Product NDC
- 16571-727
- Form
- TABLET
- Composition / generic term
- CHLORZOXAZONE
- Labeler
- Rising Pharma Holdings, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220405
- Source listing expiry
- 20261231
Source-listed ingredients
- CHLORZOXAZONE — 750 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (16571-727-01) · 16571-727-01
- 500 TABLET in 1 BOTTLE (16571-727-50) · 16571-727-50
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →